Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 8153365 Oligonucleotide analogues
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
0
Date Filed
June 3, 2010
0
Date of Patent
April 10, 2012
0
Patent Application Number
12793565
0
Patent Citations Received
US Patent 12129466 Compounds and methods for modulating UBE3A-ATS
0
US Patent 12018261 Compounds and methods for modulating factor XII
0
US Patent 12091662 Compositions for modulating tau expression
0
US Patent 12104159 PIKFYVE antisense oligonucleotides
0
US Patent 11661601 Methods for modulating FMR1 expression
0
US Patent 11713462 Modulation of GYS1 expression
0
US Patent 11753644 Compounds and methods for reducing IFNAR1 expression
US Patent 11781135 Methods for treating Alzheimer's disease
US Patent 11786546 Compounds and methods for modulating GFAP
US Patent 11788089 Compositions and methods for modulating MECP2 expression
•••
Patent Inventor Names
Jesper Wengel
0
Poul Nielsen
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
8153365
0
Patent Primary Examiner
Jezia Riley
0
Find more entities like US Patent 8153365 Oligonucleotide analogues
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE